Kite Pharma, Inc. 4
4 · Kite Pharma, Inc. · Filed May 10, 2017
Insider Transaction Report
Form 4
JENKINSON PAUL L
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-05-10$72.59/sh+3,000$217,770→ 3,000 total(indirect: See footnote) - Purchase
Common Stock
2017-05-10$72.57/sh+450$32,656→ 7,480 total
Footnotes (2)
- [F1]Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on February 17, 2017.
- [F2]The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.